Skip to main content
. 2017 Nov 2;12(11):e0185383. doi: 10.1371/journal.pone.0185383

Fig 1.

Fig 1

Compound 49b significantly increased RvD1 (A), ALX/FPR2 (B) and GPR32 (C) in the diabetic retina. Data from whole retinal lysates from C57BL/6 mice untreated (Ctrl+PBS), control mice treated with Compound 49b (Ctrl+49b), streptozotocin-induced diabetic mice (STZ+PBS), or diabetic mice treated with Compound 49b (STZ+49b). *P<0.05 vs. ctrl+PBS, #P<0.05 vs. STZ+PBS. N = 5 mice in each group.